This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order under their SPE2DB program. The $34,244.60 firm fixed-price contract is for the provision of Xolair 300 mg/2 ml auto-injectors to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to meet the pharmaceutical requirements of the Department of Defense. This contract award is not associated with any specific set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across various medical product categories.
Generated 3/5/25, 10:11 AM